Yahoo News / YouGov Coronavirus Survey: Number of Americans making plans to get vaccinated drops to 42%, a new low

“O.itemList.length” “- this.config.text.ariaShown

“+this.config.text.ariaClosed+”

So far, most of the conversation about COVID-19 vaccines has focused on the question of whether researchers can develop an effective vaccine in record time.

But maybe we should start asking another question as well: Will enough Americans actually get the vaccine for it to be effective?

“It’s a vaccine that will save us,” says Ashish Jha, director of the Harvard Global Health Institute. “It’s vaccination.”

For a COVID-19 vaccine to prevent the pandemic, scientists estimate that at least 60% of the population, and probably more than 75 or 80%, deserves to be vaccinated, a number that is based on many factors, which adds to the effectiveness of the vaccine itself and the extent of the spread of the virus.

With this in mind, Yahoo News and YouGov have been surveying other Americans in recent months: “If a coronavirus vaccine is available, will it be vaccinated?”

The lines have been daunting.

At first, the answers were favorable. In early May, 55% of Americans said yes, they would get vaccinated. But this number declined in each of the upcoming polls, to 50% at the end of May and 46% in early July.

Now, Yahoo News/YouGov’s most recent survey, conducted July 28-30, shows that 42% of Americans plan to get vaccinated instead of COVID-19, the smallest percentage to date.

Universal immunization is clouded by political considerations on both sides: skepticism about medical authority and experience (most common among Trump supporters) and suspicions (mainly among Democrats) that the administration is taking security shortcuts to precipitate vaccine production before the election.

Together, these forces threaten to undermine the COVID-19 vaccine in the United States.

Vaccines opposed to other diseases vary in their effectiveness. The measles vaccine is 95-98% effective, meaning that if another hundred people who were not exposed to measles won the measles vaccine, 95 to 98 of them would not become inflamed (on average). The effectiveness of the flu vaccine sometimes has a level of 40 to 60 consistent with the penny. The more effective a vaccine, the fewer people are needed to prevent a pandemic. The opposite is also true: as power decreases, politics will have to increase.

Last month, the U.S. Food and Drug Administration (FDA) said it would be willing to approve a 50% effective COVID-19 candidate vaccine. Such a vaccine would reduce the spread of the virus, but probably would not end the U.S. epidemic, even if all Americans were vaccinated.

If, for example, only 42% of Americans were to win such a vaccine, many lives would still be saved. As with the flu vaccine, some COVID-19 vaccines might not completely save their infection, but they could still prepare a person’s immune formula and alleviate symptoms, or even absolutely. The transmission would be packed.

Still, the pandemic would continue.

Experts say the effectiveness of all emerging COVID-19 vaccines will be more than 50%. They also expect the participation rate, i.e. that of the population who agree to be vaccinated in the short term, to exceed 42% who already say they are on board.

There are smart reasons for hope. In Yahoo New/YouGov surveys, the number of Americans who say they are not vaccinated (between 19 and 25%) is lower than the number they say they have doubts (between 26 and 33%). Together, yes and other unsafe people account for about three-quarters of the population.

Given the unprecedented speed of the existing progression procedure, it is imaginable that a COVID-19 vaccine will arrive 3 years faster than any previous vaccine, public fear about shortcuts is understandable. Overall, 34% of Americans say they are “highly feared” for protecting “accelerated” COVID-19 vaccines, according to the latest Yahoo News/YouGov survey. Another 35% said they were a little worried.

“Why do we expect Americans to settle for a vaccine before it becomes available?” Natalie Dean, a coronavirus expert, an assistant professor of biostatistics at the University of Florida, recently wrote at the New York Times. “I’m a vaccine researcher, and I even put myself in the ‘uncertain’ bucket. What we have lately is a collection of animal knowledge, immune reaction knowledge and knowledge of protection based on early trials and similar vaccines for other diseases. The evidence that would convince me to get vaccinated against COVID-19 or to claim that my loved ones are vaccinated does not yet exist.

Once the giant “phase III” or “effectiveness” tests that are just beginning have provided such evidence, the reflected image disappears, so many doubts will become themselves. And once you have a vaccine that regulators consider safe and effective, and once others see that other people are vaccinated without incident, their adoption will skyrocket. A new CBS News poll, for example, shows that 50 percent of Americans say they will “wait and see” what happens to others before they get cumed.

“Most likely for me, many activities will require a vaccine, adding many schools and some employers,” reporter Nate Silver recently predicted. “If other people see a vaccine as a price ticket to return to life in general, not only for society but also in a more literal way for them personally, it can inspire more vaccination.”

However, there is also an explanation for why other people can be led in the opposite direction, i.e. opposite vaccination.

Look what happened on the new Yahoo News/YouGov ballot when the same question was asked to Americans: “Are you going to get vaccinated?” – However, this time in situations (realistic, even likely).

Would you take a vaccine if you have side effects such as fever and headache in one-third of recipients?

The yeses fell from 42% to 35%. He doesn’t have 27% to 40%. And doubts went from 32% to 25%.

Think. About 7% of those who said yes and 7% of those who said they were unsure changed to no after discovering they have a 1 in 3 chance of having a fever or headache after being vaccinated instead of a virus that killed more. 155,000 Americans since February.

In other words, the non-unusual appearance effects were enough to turn the COVID-19 vaccine from anything Americans liked through 15 topics into something they opposed in 5.

Would you take a vaccine if it is only 60% effective in preventing COVID-19 infection?

Even more people said not in this scenario: 43%. Only 34% said yes and 23 percent said they weren’t sure.

Would you take a vaccine if I took doses for a few weeks?

This is the appropriate maximum scenario, yes (39%) and no (38%) distributed in a similar way. However, these figures represented a minimum of 3 problems for yes and an accumulation of 11 problems for no.

Would you take a vaccine if you had to wait in line for hours or make an appointment weeks in advance?

No, at least according to 42% of Americans. Again, only 39% said yes.

Overall, data on the potential disadvantages of vaccination (annoyances, inconveniences, less than overall coverage opposed to the virus) reduced the number of others who said they would be vaccinated through several percentage problems (3 to 7) while reducing the number. who said they were no longer safe (7 to 13).

In any case, they have no ground.

This suggests that Americans are as willing to reject a possible COVID-19 as they are to adopt it, especially because of these situations, most likely not to. In fact, everyone can run at the same time.

About a third of other young and healthy people who received the COVID-19 vaccine that developed through Oxford University and pharmaceutical giant AstraZeneca “suffered moderate or severe chills, fatigue, headache, discomfort and/or fever.”

One of the other most promising vaccines, Modern, requires two doses.

Again, the FDA’s efficacy threshold is 50%, which is 60%.

And it’s hard to believe how a country that took six months to administer 52 million COVID-19 tests can temporarily administer three hundred million doses of a vaccine, or six hundred million, if a booster is needed.

As a recent Washington Post report put it: “The deployment of the vaccine to others in the United States and around the world will verify and verify distribution networks, the source chain, public acceptance as true, and global cooperation. It will take months, if not years, to succeed in other people enough to make the world safe”.

Given the fragility of Americans’ existing vaccination support as opposed to COVID-19, a product, in part, of the tenacious anti-vaccine motion that has taken root in the United States over the next decade more or less, accepts as true with and cooperation in the end can make the difference between an effective vaccine and a failed vaccine.

It is simple to believe that a series of tactics in which to accept as true can be wasted and cooperation sabotaged: politics and polarization, in its best sense.

When asked about security, nearly the same number of Republicans, Democrats and independents told Yahoo News and YouGov that they were “very” or “pretty” concerned: about 70%. And while Democrats tend to have about 20 problems more likely than Republicans to say they’re going to be vaccinated, the Democratic plan to get vaccinated (15 points) has fallen more since early May than the Republican target (10 issues less)

For what? Probably because Democrats don’t accept that true with President Trump to exclude politics from the process, given that he connected his re-election hopes with the vaccine, and that the administration once announced the October deadline (i.e. before the election) for “wide-ranging public access.” “

Meanwhile, only 26% of those who intend to vote for Trump say they accept the truth with experts like the Centers for Disease Control and Prevention and the public fitness government to “judge the dangers of vaccines.” Among Joe Biden’s voters, that number is 68%.

While top experts expect a vaccine to arrive this winter, as a result of what is actually a very stormy choice, almost any misstep can turn it into an imaginable triumph of public fitness into a politicized disappointment: chain of origin problem, unfair distribution, protection shortcuts, insufficient expectations of side effects or otherwise tolerable imperfections.

It’s a political minefield, and neither party is immune.

To run a COVID-19 vaccine, Americans of all ideologies will want to get vaccinated. For months, we’ve been talking about the medical side of vaccination, and despite the encouraging signs, there’s no guarantee that an effective vaccine will arrive on time.

But even if it does, the latest data suggests another, perhaps more unsettling possibility: that America could get the medicine right and still mess this up.

_____

Leave a Comment Cancel Reply